MR-013 c3, MR013 c3	
    			    			
                TMPi008-A            
            
        General
| Cell Line | |
| hPSCreg name | TMPi008-A | 
| Cite as: | TMPi008-A (RRID:CVCL_A7JW) | 
| Alternative name(s) | 
	MR-013 c3, MR013 c3	 | 
| Cell line type | Human induced pluripotent stem cell (hiPSC) | 
| Similar lines | No similar lines found. | 
| Last update | 13th September 2024 | 
| User feedback | |
| Provider | |
| Generator | Translational Molecular Psychiatry (TMP) | 
| External Databases | |
| Cellosaurus | CVCL_A7JW | 
| Wikidata | Q107117117 | 
| BioSamples | SAMEA116046785 | 
| General Information | |
| Publications | |
| * Is the cell line readily obtainable for third parties? | No | 
Donor Information
| General Donor Information | |
| Sex | male | 
| Phenotype and Disease related information (Donor) | |
| Diseases | A disease was diagnosed. | 
| Karyotyping (Donor) | |
| Has the donor karyotype been analysed? | No | 
| Other Genotyping (Donor) | |
| Is there genome-wide genotyping or functional data available? | Yes | 
| Donor Relations | |
| Other cell lines of this donor | |
| External Databases (Donor) | |
| BioSamples | SAMEA112781131 | 
Ethics
| Has informed consent been obtained from the donor of the embryo/tissue from which the pluripotent stem cells have been derived? | Yes | 
| Was the consent voluntarily given? | Yes | 
| Has the donor been informed that participation will not directly influence their personal treatment? | Yes | 
| Can you provide us with a copy of the Donor Information Sheet provided to the donor? | Yes | 
| Do you (Depositor/Provider) hold the original Donor Consent Form? | Yes | 
| Is there other documentation provided to the donor for consenting purposes? | Yes | 
| Confirm that consent was obtained by a qualified professional | Yes | 
| Has the donor been informed about how her/his data will be protected? | Yes | 
| Please indicate whether the data associated with the donated material has been pseudonymised or anonymised. | pseudonymised | 
| Does consent explicitly allow the derivation of pluripotent stem cells? | Yes | 
| Does the consent permit uses of donated embryo/tissue or derived cell line intended for clinical treatment or human applications? | No | 
| Does consent prevent CELLS DERIVED FROM THE DONATED BIOSAMPLE from being made available to researchers anywhere in the world? | No | 
| Does consent permit research by | |
| an academic institution? | Yes | 
| a public organisation? | Yes | 
| Does consent expressly permit collection of genetic information? | Yes | 
| Does consent expressly permit storage of genetic information? | Yes | 
| Has the donor been informed that their donated biosample or derived cells may be tested for the presence of microbiological agents / pathogens? | No | 
| How may genetic information associated with the cell line be accessed? | Controlled Access | 
| Will the donor expect to receive financial benefit, beyond reasonable expenses, in return for donating the biosample? | No | 
| Does the consent permit the donor, upon withdrawal of consent, to stop the use of the derived cell line(s) that have already been created from donated samples? | Yes | 
| Does the consent permit the donor, upon withdrawal of consent, to stop delivery or use of information and data about the donor? | Yes | 
| Has a favourable opinion been obtained from a research ethics committee, or other ethics review panel, in relation to the Research Protocol including the consent provisions? | Yes | 
| Name of accrediting authority involved? | Business Administration System for Ethics Committees | 
| Approval number | BASEC-Nr.-2016-00101 & BASEC-Nr.-201700825 | 
| For generation of the cell line, who was the supplier of any recombined DNA vectors or commercial kits used? | |
hIPSC Derivation
| General | |
| Source cell type | A peripheral blood cell with a single nucleus. This category includes lymphocytes and monocytes. Synonyms 
 | 
| Reprogramming method | |
| Vector type | Non-integrating | 
| Vector | Sendai virus | 
| Is reprogramming vector detectable? | No | 
| Methods used | 
	RT-PCR	 | 
| Files and images showing reprogramming vector expressed or silenced | |
| Vector free reprogramming | |
| Other | |
| Derived under xeno-free conditions | Unknown | 
| Derived under GMP? | Unknown | 
| Available as clinical grade? | Unknown | 
Culture Conditions
| Medium | Essential 8™ Flex | 
Characterisation
Analysis of Undifferentiated Cells
| Marker | Expressed | Immunostaining | RT-PCR | Flow Cytometry | Enzymatic Assay | Expression Profiles | 
| SSEA-4 | Yes | |||||
| TRA 1-60 | Yes | |||||
| POU5F1 (OCT-4) | Yes | |||||
| SOX2 | Yes | |||||
| LIN28A | Yes |  | ||||
| NANOG | Yes | 
Genotyping
| Karyotyping (Cell Line) | |
| Has the cell line karyotype been analysed? | No | 
| Other Genotyping (Cell Line) | |

Login to share your feedback, experiences or results with the research community.